GL1X · GenesisL1 explorer

MolNFT v1 · #175460 · protein

Crystal structure of human TLR8 in complex with cu-CPD107

7CRF · Toll-like receptor 8: “Crystal structure of human TLR8 in complex with cu-CPD107”. X-ray diffraction, 4 ligands (GD0, NAG, MAN), 11 pockets (best druggability 0.75). MolNFT v1 #175460 on GenesisL1: 3D structure, binding sites and…

PDB
7CRF
Type
protein
Length
1,495 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Toll-like receptor 8
UniProt
Q9NR97
Ligands
GD0, NAG, MAN, BMA
Pockets
11 · best druggability 0.75

Structure

x-ray diffraction · 2 distinct chains · 10% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AToll-like receptor 8protein74410% helix, 16% strandQ9NR97
BToll-like receptor 8protein75110% helix, 16% strandQ9NR97

Ligands and binding sites

  • GD0 · 1-[2-(ethoxymethyl)-4-iodanyl-5-phenyl-imidazol-1-yl]-2-methyl-propan-2-ol · ligand · 2 copies · chains A, B
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 33 copies · chains A, B
  • MAN · alpha-D-mannopyranose · sugar · 14 copies · chains A, B
  • BMA · beta-D-mannopyranose · sugar · 6 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 7 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18200.750.7993NAG, GD0
25640.720.8073NAG, GD0
34770.660.7851empty
43340.600.7743NAG
52370.590.7930NAG

Interfaces

1 interface between chains.

  • A–B · 1166 Ų buried · 4 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 27 glycan, 13 disulfide (N-glycosylation, disulfide).

Compared structures

  • 7CRF · Crystal structure of human TLR8 in complex with CU-CPD107 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.